NEW YORK (GenomeWeb News) - Illumina today said it will acquire next-generation sequencing firm Solexa in a stock deal worth approximately $600 million.
 
Under the terms of the agreement, Solexa shareholders will receive Illumina common stock at $14 per share, and Illumina will invest $50 million in Solexa for newly issued Solexa shares.
 
Solexa’s shares were trading at $9.70 at market close on Friday and the company’s market capitalization was $354 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.